Published on 4 Mar 2024 on GuruFocus.com via Yahoo Finance
Insider Sell: President and CEO Richard Paulson Sells 99,844 Shares of Karyopharm Therapeutics ...
President and CEO Richard Paulson executed a sale of 99,844 shares of Karyopharm Therapeutics Inc (NASDAQ:KPTI) on March 1, 2024, according to a recent SEC Filing. The transaction was reported to have occurred at an average price of $1.18 per share, resulting in a total sale value of $117,816.72.
Warning! GuruFocus has detected 6 Warning Signs with KPTI.
Karyopharm Therapeutics Inc is a pharmaceutical company focused on the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases.